Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
Status:
Withdrawn
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
To determine the appropriate dose and safety of a preventative dose of fondaparinux, an
anticoagulant medication (blood thinner) in patients with kidney disease.